NTLA
Intellia Therapeutics, Inc. · Healthcare
Orbimed Advisors LLC bought $4.5M of Intellia Therapeutics, Inc.
Director
Bought$4,500,000
$18.00Price
250,000Shares
+10%Stake
What NTLA did for a copier
Prices for NTLA after this filing aren't in yet.
Orbimed Advisors LLC's record
35 other buys with 3 months of prices since 2016: on average −12.5% against the S&P 500, and 12 of 35 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, May 11. Filed Fri, May 13, 4:58 PM ET, after the close. Not investment advice.